MedTrace Logo

The Predictive Role of HPV Integration in HSIL and Cervical Cancer

NCT05300243 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2022-03-29

No results posted yet for this study

Summary

The stratified analysis by the level of HPV DNA integration in HSIL and cervical cancer will be drawn to explore whether the status of HPV integration makes any difference in the progression of cervical cancer. The purpose of the research is to reduce the miss of cervix lesions and prove that HPV integration detection is sensitive in cervical cancer precise screening.

Conditions

  • HPV Integration

Interventions

DIAGNOSTIC_TEST

HPV integration test

The stratified analysis by the level of HPV DNA integration in HSIL and cervical cancer will be drawn to explore whether the status of HPV integration makes any difference in the progression of cervical cancer. The purpose of the research is to reduce the miss of cervix lesions and prove that HPV integration detection is sensitive in cervical cancer precise screening.

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Shuang Li · Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-07
Primary Completion
2022-04-01
Completion
2022-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05300243 on ClinicalTrials.gov